Genentech Brain Trust Raises $217m For New Startup To Fight Alzheimers And Parkinsons

May 14, 2015 | Three former top researchers at Genentech, the legendary biotech that is now part of Roche Holding, have raised $217 million in venture capital to start a new company, Denali Therapeutics, focused on treating and curing neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's. Forbes